Ionotropic and metabotropic glutamate receptor structure and pharmacology.
BACKGROUND
L: -Glutamate is the major excitatory neurotransmitter in the central nervous system (CNS) and mediates its actions via activation of both ionotropic and metabotropic receptor families. The development of selective ligands, including competitive agonists and antagonists and positive and negative allosteric modulators, has enabled investigation of the functional roles of glutamate receptor family members.


OBJECTIVE
In this review we describe the subunit structure and composition of the ionotropic and metabotropic glutamate receptors and discuss their pharmacology, particularly with respect to selective tools useful for investigation of their function in the CNS.


RESULTS
A large number of ligands are now available that are selective either for glutamate receptor subfamilies or for particular receptor subtypes. Such ligands have enabled considerable advances in the elucidation of the physiological and pathophysiological roles of receptor family members. Furthermore, efficacy in animal models of neurological and psychiatric disorders has supported the progression of several glutamatergic ligands into clinical studies. These include ionotropic glutamate receptor antagonists, which have entered clinical trials for disorders including epilepsy and ischaemic stroke, alpha-amino-3-hydroxy-5-methyl-4-isoazolepropionic acid (AMPA) receptor positive allosteric modulators which are under evaluation as cognitive enhancers, and metabotropic glutamate receptor 2 (mGluR2) agonists which are undergoing clinical evaluation as anxiolytics. Furthermore, preclinical studies have illustrated therapeutic potential for ligands selective for other receptor subtypes in various disorders. These include mGluR1 antagonists in pain, mGluR5 antagonists in anxiety, pain and drug abuse and mGluR5 positive allosteric modulators in schizophrenia.


CONCLUSIONS
Selective pharmacological tools have enabled the study of glutamate receptors. However, pharmacological coverage of the family is incomplete and considerable scope remains for the development of novel ligands, particularly those with in vivo utility, and for the their use together with existing tools for the further investigation of the roles of receptor family members in CNS function and as potentially novel therapeutics.
Kew
James N C
JN
Psychiatry Centre of Excellence for Drug Discovery, GlaxoSmithKline, New Frontiers Science Park, Harlow, Essex CM19 5AW, UK. james_n_kew@gsk.com
Kemp
John A
JA
D000494:Allosteric Regulation; D000818:Animals; D001667:Binding, Competitive; D018690:Excitatory Amino Acid Agonists / Q000494:pharmacology*; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology*; D006801:Humans; D008024:Ligands; D018091:Receptors, AMPA / Q000737:chemistry* / Q000187:drug effects; D018092:Kainic Acid Receptors / Q000737:chemistry* / Q000187:drug effects; D018094:Receptors, Metabotropic Glutamate / Q000737:chemistry* / Q000187:drug effects; D016194:Receptors, N-Methyl-D-Aspartate / Q000737:chemistry* / Q000187:drug effects
D018690:Excitatory Amino Acid Agonists; D018691:Excitatory Amino Acid Antagonists; D008024:Ligands; D018091:Receptors, AMPA; D018092:Kainic Acid Receptors; D018094:Receptors, Metabotropic Glutamate; D016194:Receptors, N-Methyl-D-Aspartate
Physiol Rev. 1994 Jul;74(3):723-60
8036251
J Pharmacol Exp Ther. 1999 Oct;291(1):161-70
10490900
J Neurochem. 1997 Jul;69(1):174-81
9202308
Geriatrics. 2004 Jun;59(6):22-7
15224791
CNS Drug Rev. 2002 Winter;8(4):337-52
12481190
Neuron. 1995 Jul;15(1):193-204
7619522
FEBS Lett. 1992 Nov 16;313(1):34-8
1385220
Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):2660-5
11867751
Curr Opin Investig Drugs. 2002 Jul;3(7):1081-8
12186271
J Biol Chem. 2003 Mar 7;278(10):8340-7
12509432
J Med Chem. 1995 Sep 15;38(19):3717-9
7562903
J Biol Chem. 1993 Feb 5;268(4):2836-43
8428958
J Med Chem. 2004 Aug 26;47(18):4595-9
15317469
Proc Natl Acad Sci U S A. 1996 Jun 11;93(12):6031-6
8650214
Pharmacol Rev. 1999 Mar;51(1):7-61
10049997
Mol Pharmacol. 1995 Feb;47(2):374-80
7870047
Nature. 1998 Aug 13;394(6694):683-7
9716132
J Neurochem. 1998 Oct;71(4):1464-70
9751179
Biophys J. 1991 Mar;59(3):560-73
1710938
Mol Pharmacol. 1997 Nov;52(5):861-73
9351977
Mol Pharmacol. 1994 Dec;46(6):1191-6
7808441
Neuropharmacology. 1999 Oct;38(10 ):1493-503
10530811
J Pharmacol Exp Ther. 1999 Sep;290(3):1026-33
10454474
Bioorg Med Chem Lett. 2003 Oct 6;13(19):3155-9
12951084
J Med Chem. 1997 Oct 24;40(22):3700-5
9357538
Science. 1998 Jun 5;280(5369):1596-9
9616121
Neuroreport. 1992 Dec;3(12):1138-40
1493227
J Med Chem. 2001 Feb 1;44(3):302-4
11462971
J Med Chem. 1994 Jan 21;37(2):260-7
8295213
J Comp Neurol. 1993 Dec 15;338(3):377-90
8113446
J Med Chem. 1997 Feb 14;40(4):528-37
9046344
J Neurochem. 2002 Aug;82(4):794-800
12358784
J Med Chem. 1997 Mar 14;40(6):841-50
9083472
Trends Pharmacol Sci. 1993 Jan;14(1):20-5
8382885
Curr Drug Targets CNS Neurol Disord. 2002 Feb;1(1):1-16
12769631
J Physiol. 1990 May;424:533-43
1975272
Nat Neurosci. 2001 Apr;4(4):417-23
11276233
Br J Pharmacol. 2002 Aug;136(7):1033-41
12145103
J Neurosci. 1993 Sep;13(9):3904-15
8103555
Neurosci Lett. 1988 Apr 22;87(1-2):104-8
2837683
J Biol Chem. 1996 Nov 8;271(45):28612-6
8910492
J Neurosci. 1997 Aug 1;17(15):5760-71
9221774
J Pharmacol Exp Ther. 2003 Jul;306(1):116-23
12660307
Nat Neurosci. 2001 Sep;4(9):873-4
11528416
Bioorg Med Chem Lett. 2003 Mar 10;13(5):829-32
12617901
Brain Res Mol Brain Res. 2002 Apr 30;100(1-2):43-52
12008020
Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10960-5
9724812
Nat Neurosci. 2002 Nov;5 Suppl:1039-42
12403981
J Pharmacol Exp Ther. 1999 Jun;289(3):1678-87
10336568
Curr Pharm Des. 2002;8(10):873-85
11945137
Bioorg Med Chem Lett. 2000 Jun 5;10(11):1203-5
10866381
Farmaco. 2002 Dec;57(12):989-92
12564473
Cell Signal. 1997 Jan;9(1):1-13
9067625
Epilepsy Res. 2004 Mar;59(1):1-12
15135162
Eur J Pharmacol. 1994 Mar 15;267(1):77-84
7515823
J Pharmacol Exp Ther. 2004 Jun;309(3):1003-10
14985418
Mol Pharmacol. 2003 Sep;64(3):731-40
12920211
Mol Pharmacol. 1999 Mar;55(3):453-61
10051528
Mol Pharmacol. 2003 Oct;64(4):823-32
14500738
Trends Pharmacol Sci. 1990 Jan;11(1):25-33
2155495
Curr Opin Pharmacol. 2004 Feb;4(1):4-11
15018832
Science. 1990 Feb 2;247(4942):571-4
2154034
J Med Chem. 1994 Feb 18;37(4):467-75
8120865
Nature. 1994 Mar 10;368(6467):144-7
8139656
J Med Chem. 2004 Nov 18;47(24):5825-8
15537338
Ann N Y Acad Sci. 2003 Apr;985:150-62
12724156
J Cereb Blood Flow Metab. 1995 Mar;15(2):197-204
7860653
Stroke. 2002 Dec;33(12):2813-8
12468775
Mol Pharmacol. 2003 Oct;64(4):798-810
14500736
J Neurosci. 2002 Jul 15;22(14):5955-65
12122058
Mol Pharmacol. 2000 Dec;58(6):1310-7
11093768
Physiol Rev. 2001 Jul;81(3):971-98
11427689
Bioorg Med Chem Lett. 1998 Apr 7;8(7):765-70
9871538
Eur J Pharmacol. 2004 Oct 1;500(1-3):129-42
15464027
Neuroscience. 1996 Jul;73(2):429-47
8783260
Behav Pharmacol. 2003 Jul;14(4):257-77
12838033
J Neurosci. 2000 Jun 1;20(11):4037-49
10818139
Mol Pharmacol. 2001 Nov;60(5):944-54
11641422
J Physiol. 1996 Mar 15;491 ( Pt 3):719-33
8815206
Bioorg Med Chem Lett. 2003 May 19;13(10):1759-62
12729659
Mol Pharmacol. 2000 Sep;58(3):614-23
10953056
Psychopharmacology (Berl). 2004 Sep;175(3):310-8
15024550
Eur J Pharmacol. 2004 Sep 13;498(1-3):153-6
15363989
J Neurochem. 1994 Aug;63(2):769-72
8035201
Pharmacol Ther. 2003 Jun;98(3):325-54
12782243
Trends Pharmacol Sci. 2001 Jul;22(7):355-61
11431030
J Pharmacol Exp Ther. 1996 Nov;279(2):492-501
8930150
J Neurosci. 2000 Nov 15;20(22):8269-78
11069933
Eur J Pharmacol. 1997 Apr 4;323(2-3):181-92
9128837
J Biol Chem. 2000 Oct 27;275(43):33750-8
10934211
J Med Chem. 1994 Nov 25;37(24):4053-67
7990104
Nature. 2000 Oct 26;407(6807):971-7
11069170
J Neurosci. 1998 Mar 15;18(6):1935-43
9482779
Br J Pharmacol. 2004 Feb;141(3):508-16
14718249
J Mol Evol. 1987;25(4):351-60
3118049
J Pharmacol Exp Ther. 2002 Sep;302(3):940-8
12183650
Bioorg Med Chem Lett. 2004 Nov 15;14(22):5477-80
15482907
Drug News Perspect. 2004 May;17 (4):251-7
15334174
Neuropharmacology. 1998 Dec;37(12):1645-7
9886688
J Neurosci. 2003 Jan 15;23(2):422-9
12533602
J Neurochem. 2000 Sep;75(3):889-907
10936169
Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13668-73
14593202
J Pharmacol Exp Ther. 2003 Dec;307(3):897-905
14534359
J Neurosci. 2001 Dec 1;21(23):RC185
11717388
Neuron. 1994 Jun;12(6):1291-300
8011339
J Biol Chem. 2003 Aug 8;278(32):30294-301
12764131
Neuropharmacology. 2001 Jun;40(8):976-83
11406188
J Med Chem. 2000 May 18;43(10):1958-68
10821708
Nucleic Acids Res. 1997 Dec 15;25(24):4876-82
9396791
Neuron. 1994 Mar;12(3):529-40
7512349
J Biol Chem. 2002 Mar 1;277(9):7333-40
11744707
Bioorg Med Chem Lett. 2002 Apr 8;12(7):1099-102
11909726
Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8969-74
9671788
J Med Chem. 1995 Aug 4;38(16):3138-45
7636876
J Biol Chem. 1993 Jun 5;268(16):11868-73
8389366
Stroke. 1997 Jun;28(6):1255-62; discussion 1263
9183359
Mol Pharmacol. 2002 Nov;62(5):1119-27
12391275
Bioorg Med Chem Lett. 2003 Feb 24;13(4):693-6
12639560
J Pharmacol Exp Ther. 1997 May;281(2):721-9
9152378
J Neurosci. 2003 Feb 15;23(4):1151-8
12598603
J Med Chem. 1999 Jul 29;42(15):2993-3000
10425109
Nature. 1998 May 28;393(6683):377-81
9620802
Br J Pharmacol. 2002 Feb;135(4):901-9
11861317
Neuropharmacology. 2001 Jun;40(8):1010-8
11406192
J Med Chem. 2000 Dec 14;43(25):4893-909
11123999
J Neurochem. 2003 Sep;86(6):1414-27
12950450
Curr Opin Neurobiol. 2003 Jun;13(3):271-8
12850210
Synapse. 2003 Dec 15;50(4):269-76
14556231
Bioorg Med Chem Lett. 2004 Nov 15;14(22):5473-6
15482906
Nature. 2002 Feb 14;415(6873):793-8
11823786
Epilepsia. 2003 Jan;44(1):46-53
12581229
J Neurosci. 1994 May;14(5 Pt 2):3370-7
8182479
Curr Pharm Des. 2002;8(10):857-72
11945136
Bioorg Med Chem Lett. 2003 Feb 10;13(3):351-4
12565928
Stroke. 2003 Jan;34(1):171-6
12511770
J Neurosci. 2002 May 15;22(10):3881-9
12019307
Neuropharmacology. 2002 Dec;43(8):1199-209
12527469
J Pharmacol Exp Ther. 1999 Jul;290(1):170-81
10381773
Bioorg Med Chem. 2003 Apr 17;11(8):1769-80
12659763
J Med Chem. 2003 Jul 17;46(15):3189-92
12852748
Neuron. 1997 Mar;18(3):493-503
9115742
Nature. 1997 Oct 9;389(6651):599-603
9335499
Neuron. 1997 Nov;19(5):1141-6
9390526
Nature. 2002 May 16;417(6886):245-53
12015593
Mol Pharmacol. 2000 Oct;58(4):802-13
10999951
Neuropharmacology. 2000 Jul 24;39(10 ):1700-6
10884552
Proc Natl Acad Sci U S A. 2004 May 25;101(21):8198-203
15150412
J Biol Chem. 2000 Sep 8;275(36):28144-51
10874032
Neuropharmacology. 2004 Jul;47(1):46-64
15165833
Neuropharmacology. 1998 Oct-Nov;37(10-11):1261-7
9849663
J Med Chem. 1999 Mar 25;42(6):1027-40
10090786
J Pharmacol Exp Ther. 2002 Dec;303(3):1075-85
12438530
J Med Chem. 2004 Apr 8;47(8):2089-96
15056006
Curr Pharm Des. 2002;8(10):913-39
11945139
J Biol Chem. 2003 Feb 7;278(6):4314-21
12444084
Neuron. 1995 Aug;15(2):453-62
7646897
J Med Chem. 2003 Jan 16;46(2):204-6
12519057
Neuropharmacology. 2003 Dec;45(7):895-906
14573382
Proc Natl Acad Sci U S A. 1986 Sep;83(18):7104-8
3529096
J Neurochem. 1988 Sep;51(3):830-6
2457653
J Pharmacol Exp Ther. 1999 Oct;291(1):285-91
10490915
J Biol Chem. 2004 Aug 20;279(34):35526-34
15199056
Nat Struct Mol Biol. 2004 Aug;11(8):706-13
15235591
J Neurosci. 1998 Jan 15;18(2):581-9
9425000
Curr Drug Targets CNS Neurol Disord. 2004 Jun;3(3):181-94
15180479
Proc Natl Acad Sci U S A. 2004 Jan 6;101(1):378-83
14691258
J Neurosci. 2002 Sep 15;22(18):8010-7
12223554
J Neurophysiol. 2002 Apr;87(4):2052-63
11929923
J Pharmacol Exp Ther. 2004 May;309(2):568-77
14747613
Mol Pharmacol. 1993 Oct;44(4):851-9
7901753
Neuron. 2000 Oct;28(1):165-81
11086992
Brain Res. 2002 Jul 19;944(1-2):165-73
12106676
J Med Chem. 1996 Jan 19;39(2):343-6
8558499
Neuron. 1991 Oct;7(4):605-13
1681832
Curr Opin Neurobiol. 2003 Jun;13(3):279-83
12850211
Mol Pharmacol. 2004 Jun;65(6):1386-96
15155832
J Physiol. 1998 Oct 1;512 ( Pt 1):17-28
9729614
Science. 1992 May 22;256(5060):1217-21
1350383
J Pharmacol Exp Ther. 2003 Aug;306(2):752-62
12730350
Bioorg Med Chem Lett. 2004 Nov 15;14(22):5481-4
15482908
Curr Drug Targets CNS Neurol Disord. 2002 Apr;1(2):215-25
12769628
Proc Natl Acad Sci U S A. 2001 Nov 6;98(23):13402-7
11606768
Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3172-7
14766987
Neuropharmacology. 2004 Jun;46(7):907-17
15081787
CNS Drug Rev. 2002 Fall;8(3):255-82
12353058
Bioorg Med Chem Lett. 2002 Sep 16;12(18):2615-9
12182873
Br J Pharmacol. 2003 Mar;138(6):1026-30
12684257
Bioorg Med Chem Lett. 2001 Jan 22;11(2):177-81
11206453
J Neurochem. 1997 Feb;68(2):469-78
9003031
Neuropharmacology. 1995 Oct;34(10):1239-58
8570022
Brain Res Brain Res Rev. 1999 Jan;29(1):83-120
9974152
CNS Drug Rev. 2002 Fall;8(3):235-54
12353057
Bioorg Med Chem Lett. 2003 Feb 24;13(4):697-700
12639561
Nature. 1998 Oct 29;395(6705):913-7
9804426
Neurosci Lett. 2002 Sep 20;330(2):127-30
12231428
Neuropharmacology. 2001 Mar;40(3):311-8
11166323
Nature. 1992 Jul 2;358(6381):36-41
1377365
Neuropharmacology. 1997 Feb;36(2):265-7
9144665
Psychopharmacology (Berl). 2003 Aug;168(4):446-54
12709777
Neuropharmacology. 2002 Feb;42(2):143-53
11804610
Neuropharmacology. 1996;35(12):1689-702
9076748
Neuropharmacology. 2004 May;46(6):793-806
15033339
J Neurosci. 1995 Oct;15(10):6498-508
7472412
Mol Pharmacol. 1998 May;53(5):942-9
9584222
Neuron. 1995 Nov;15(5):1109-20
7576654
Neuropharmacology. 1998 Aug;37(8):1043-51
9833633
Mol Pharmacol. 2001 May;59(5):965-73
11306677
Br J Pharmacol. 1983 Jun;79(2):565-75
6317114
Mol Pharmacol. 1999 Dec;56(6):1207-18
10570048
Annu Rev Physiol. 2004;66:161-81
14977400
Mol Pharmacol. 2003 May;63(5):1082-93
12695537
J Pharm Pharmacol. 1998 Jul;50(7):795-801
9720630
Br J Pharmacol. 1998 Aug;124(8):1767-73
9756395
Neurology. 2002 Jun 11;58(11):1680-2
12058100
Neuropharmacology. 1999 Oct;38(10):1431-76
10530808
Eur J Pharmacol. 1988 Oct 26;156(1):177-80
2905271
Brain Res Bull. 2001 Jun;55(3):387-91
11489346
Behav Pharmacol. 2003 Sep;14(5-6):477-87
14501261
Br J Pharmacol. 1998 Feb;123(3):463-72
9504387
Neuropharmacology. 2001 Apr;40(5):732-5
11311902
J Neurochem. 1995 Feb;64(2):531-9
7830045
J Pharmacol Exp Ther. 1997 Dec;283(3):1285-92
9400004
Nature. 1992 May 7;357(6373):70-4
1374164
J Neurochem. 1997 Jun;68(6):2424-34
9166736
J Med Chem. 1997 Dec 5;40(25):4053-68
9406596
Neuropharmacology. 1998;37(1):1-12
9680254
Stress. 2003 Sep;6(3):189-97
13129812
Br J Pharmacol. 1998 Jan;123(2):269-74
9489615
Nature. 1999 Nov 18;402(6759):297-301
10580501
Eur J Pharmacol. 1989 Aug 3;166(3):591-2
2553441
Neuropharmacology. 2001;40(1):10-9
11077066